Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia
Clinical trial NCT05685420 · UNKNOWN
Trial details
- NCT number
- NCT05685420
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2024-06-30
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.